tiprankstipranks
Trending News
More News >
Oncolys BioPharma, Inc. (JP:4588)
:4588
Japanese Market

Oncolys BioPharma, Inc. (4588) Revenue

Compare
1 Followers

Oncolys BioPharma, Inc. Revenue

Oncolys BioPharma, Inc. had a revenue of 28.55M in the quarter ending Jun 30, 2025, with Infinity%. This bring the company's revenue in the last twelve months to 28.55M, Increased -9.04%. In the fiscal year ending Dec 31, 2025, Oncolys BioPharma, Inc. had annual revenue of 28.55M with -9.04% growth.
Revenue (ttm)
28.55M
Revenue Growth
-9.04%
P/S Ratio
2448.36
Revenue/Employee
¥713,650
Employees
40
Market Cap
¥69.89B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
28.55M-2.84M-9.04%
Dec 31, 2024
31.38M-31.65M-50.21%
Dec 31, 2023
63.04M-913.14M-93.54%
Dec 31, 2022
976.18M333.69M+51.94%
Dec 31, 2021
642.49M328.31M+104.50%
Dec 31, 2020
314.18M-989.66M-75.90%
Dec 31, 2019
1.30B1.14B+673.57%
Dec 31, 2018
168.55M-60.59M-26.44%
Dec 31, 2017
229.14M